PinkDx raised $5M in additional Series A funding led by Catalio Capital Management to advance its first test for diagnosing potential gynecologic cancer.
PinkDx raised $5M in additional Series A funding led by Catalio Capital Management to advance its first test for diagnosing potential gynecologic cancer.
01/24/25, 9:14 AM
Location
daly cityMoney raised
$5 million
Industry
biotechnology
Round Type
series a
Investors
Bevc, Sandbox Clinical Ventures, Blue Venture Fund, Mayo Clinic, Byers Capital, Mountain Group Partners, The Production Board, Catalio Capital Management
PinkDx, based in Daly City, CA, has secured an additional $5M in Series A funding to enhance its diagnostic test for women potentially facing gynecologic cancer. This round was led by Catalio Capital Management, with participation from several new investors and existing backers.
Company Info
Location
2001 junipero serra blvd., suite 610
daly city, california, united states
Additional Info
PinkDx is an early-stage company focused on addressing the medical problems that women uniquely face by applying sophisticated scientific approaches to resolve them and providing answers that have an immediate, positive impact on their lives. The company's first indication will focus on overcoming diagnostic challenges for women who present with general symptoms that could signal a gynecological cancer.